Loading clinical trials...
Loading clinical trials...
Once Weekly Semaglutide Treatment of Trichotillomania: An Open-Label Study
Conditions
Interventions
Semaglutide
Start Date
February 1, 2026
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2027
Last Updated
December 17, 2025
NCT07224126
NCT05796752
NCT05003401
NCT04241120
NCT00775229
NCT00354770
Lead Sponsor
University of Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions